Podcasts

Third-generation FLT3 inhibitors in clinical development

Published: Oct. 26, 2018, 4:17 p.m.
Duration: 2 minutes 42 seconds

Listed in: Science

CAR T case study in acute myeloid leukemia

Published: Oct. 5, 2018, 4:33 p.m.
Duration: 5 minutes 49 seconds

Listed in: Science

Key considerations when prescribing midostaurin with a strong CYP3A4 inhibi

Published: Oct. 5, 2018, 4:33 p.m.
Duration: 2 minutes 23 seconds

Listed in: Science

How to proceed with a patient who presents with idiopathic cytopenia of undetermined significance

Published: March 20, 2018, 5:49 p.m.
Duration: 3 minutes 58 seconds

Listed in: Science

When to consider iron chelation therapy for a transplant-eligible patient

Published: March 20, 2018, 5:48 p.m.
Duration: 3 minutes 56 seconds

Listed in: Science

53-year-old woman presenting with severe fatigue and bruising

Published: March 20, 2018, 5:47 p.m.
Duration: 3 minutes 58 seconds

Listed in: Science

New subcategories of pancreatic cancer allow for a biomarker-driven approach to therapy

Published: Jan. 5, 2018, 6:43 p.m.
Duration: 4 minutes

Listed in: Science

What are the unique aspects of pancreas cancer that lead to the development of novel therapeutics?

Published: Jan. 5, 2018, 6:40 p.m.
Duration: 2 minutes 40 seconds

Listed in: Science

Predictors of response to lenalidomide in a non-del(5q) MDS patient

Published: Jan. 5, 2018, 6:36 p.m.
Duration: 3 minutes 3 seconds

Listed in: Science

What are the pros and cons of radiation therapy?

Published: Dec. 21, 2017, 5:13 p.m.
Duration: 2 minutes 29 seconds

Listed in: Science

What defines high-quality survivorship care for patients treated for classical Hodgkin lymphoma?

Published: Nov. 30, 2017, 9:14 p.m.
Duration: 3 minutes 1 second

Listed in: Science

Second primary malignancies associated with lenalidomide maintenance

Published: Nov. 30, 2017, 9:08 p.m.
Duration: 2 minutes 53 seconds

Listed in: Science

Impact of consolidation therapy in patients post-transplant

Published: Nov. 30, 2017, 9:08 p.m.
Duration: 3 minutes 9 seconds

Listed in: Science

Bortezomib as an alternate strategy for maintenance therapy.

Published: Oct. 23, 2017, 5:22 p.m.
Duration: 2 minutes 32 seconds

Listed in: Science

What may be the future role for brentuximab vedotin in newly diagnosed Hodgkin lymphoma?

Published: Oct. 23, 2017, 5:22 p.m.
Duration: 2 minutes 35 seconds

Listed in: Science

Has MRD testing become a standard of care in multiple myeloma?

Published: Oct. 23, 2017, 5:22 p.m.
Duration: 3 minutes 22 seconds

Listed in: Science

The Precision Promise [SM] Initiative: What is it designed to achieve?

Published: Sept. 27, 2017, 5:23 p.m.
Duration: 4 minutes 32 seconds

Listed in: Science

Enasidenib in mutant-IDH2 R/R AML: Results of a phase 1 dose-escalation and expansion study

Published: Sept. 27, 2017, 5:17 p.m.
Duration: 8 minutes 26 seconds

Listed in: Science

What are the optimal imaging methods to determine extent of bone disease in newly diagnosed MM?

Published: Sept. 27, 2017, 5:03 p.m.
Duration: 3 minutes 18 seconds

Listed in: Science

The standard of care for patients receiving lenalidomide or thalidomide who are at high risk for VTE

Published: Sept. 27, 2017, 5:03 p.m.
Duration: 3 minutes 36 seconds

Listed in: Science

How do I dose daratumumab, lenalidomide and dexamethasone in the combination regimen?

Published: Sept. 27, 2017, 5:03 p.m.
Duration: 1 minute 59 seconds

Listed in: Science

Is there a connection between pancreatic cancer and new-onset diabetes?

Published: Aug. 18, 2017, 7:08 p.m.
Duration: 8 minutes 26 seconds

Listed in: Science

CPX versus 7 and 3 conventional chemotherapy in older adults with AML

Published: Aug. 18, 2017, 7:03 p.m.
Duration: 3 minutes 16 seconds

Listed in: Science

How long should I be infusing carfilzomib intravenously?

Published: Aug. 18, 2017, 7:01 p.m.
Duration: 2 minutes 55 seconds

Listed in: Science

What is the current status of immunotherapy in pancreatic cancer?

Published: Aug. 2, 2017, 6:09 p.m.
Duration: 4 minutes 37 seconds

Listed in: Science

Measuring Frailty in Patients Being Treated for Multiple Myeloma

Published: Aug. 2, 2017, 6:09 p.m.
Duration: 1 minute 49 seconds

Listed in: Science

Differentiation syndrome associated with enasidenib, a selective inhibitor of mutant IDH2

Published: Aug. 2, 2017, 6:09 p.m.
Duration: 4 minutes 4 seconds

Listed in: Science

How do I dose daratumumab, bortezomib and dexamethasone in the combination regimen?

Published: Aug. 2, 2017, 6:09 p.m.
Duration: 3 minutes 17 seconds

Listed in: Science

Update on the CALGB-100104 (Alliance) randomized trial

Published: Aug. 2, 2017, 6:09 p.m.
Duration: 3 minutes 26 seconds

Listed in: Science

How does the safety profile of the new and emerging anti-PD 1 antibodies differ from chemotherapy?

Published: July 12, 2017, 4:39 p.m.
Duration: 1 minute 55 seconds

Listed in: Science

ELOQUENT-2 updates represent the longest median FU of an immuno-oncology agent in MM

Published: July 12, 2017, 4:36 p.m.
Duration: 1 minute 43 seconds

Listed in: Science

Optimal Pre-medication Strategy for Daratumumab

Published: July 12, 2017, 4:34 p.m.
Duration: 2 minutes 9 seconds

Listed in: Science

Rash Management for Patients Taking IRd (Ixazomib-Lenalidomide-Dexamethasone)

Published: June 29, 2017, 2:37 p.m.
Duration: 1 minute 28 seconds

Listed in: Science

What is the appropriate management for severe hypercalcemia?

Published: June 29, 2017, 2:35 p.m.
Duration: 2 minutes 31 seconds

Listed in: Science

What is the most common cause of renal failure in newly diagnosed patients with multiple myeloma?

Published: June 29, 2017, 2:33 p.m.
Duration: 1 minute 54 seconds

Listed in: Science

Standard dosing and delivery of Nal-IRI + 5-FU/LV

Published: June 29, 2017, 2:29 p.m.
Duration: 2 minutes 21 seconds

Listed in: Science

How important is the availability of supportive care when considering transplant in older patients?

Published: May 15, 2017, 2:48 p.m.
Duration: 2 minutes 26 seconds

Listed in: Science

Is the AE profile of BV the same or different from traditional monoclonal antibody therapies?

Published: May 15, 2017, 2:12 p.m.
Duration: 2 minutes 9 seconds

Listed in: Science

When do you need to do a bone marrow biopsy in the management or assessment of multiple myeloma?

Published: May 15, 2017, 2:07 p.m.
Duration: 2 minutes 37 seconds

Listed in: Science

What are some of the more common adverse reactions associated with brentuximab vedotin?

Published: April 28, 2017, 5:39 p.m.
Duration: 2 minutes 49 seconds

Listed in: Science

What are the different technologies used to assess cytogenetic risk status?

Published: April 28, 2017, 5:27 p.m.
Duration: 2 minutes 17 seconds

Listed in: Science

What is meant by the term high-risk myeloma?

Published: April 28, 2017, 5:22 p.m.
Duration: 2 minutes 30 seconds

Listed in: Science

Standard dosing and delivery of FOLFIRINOX

Published: April 28, 2017, 5:17 p.m.
Duration: 2 minutes 24 seconds

Listed in: Science

The new FDA approval of pembrolizumab for cHL

Published: March 23, 2017, 8:31 p.m.
Duration: 4 minutes 36 seconds

Listed in: Science

Standard dosing and delivery of gemcitabine/nab-paclitaxel

Published: March 23, 2017, 3:29 p.m.
Duration: 2 minutes 22 seconds

Listed in: Science

How do I diagnose chronic myelomonocytic leukemia (CMML)?

Published: March 9, 2017, 4:25 p.m.
Duration: 3 minutes 35 seconds

Listed in: Science

What tests should I obtain upfront at the time of MDS diagnosis?

Published: Feb. 23, 2017, 5:57 p.m.
Duration: 2 minutes 58 seconds

Listed in: Science

How do I manage diarrhea in my patients taking ixazomib?

Published: Feb. 7, 2017, 8:53 p.m.
Duration: 1 minute 22 seconds

Listed in: Science

What prophylactic antithrombotic agents are safe to use with lenalidomide?

Published: Feb. 7, 2017, 8:52 p.m.
Duration: 1 minute 22 seconds

Listed in: Science

How do I manage renal dysfunction in my patient who is taking lenalidomide?

Published: Feb. 7, 2017, 8:50 p.m.
Duration: 1 minute 22 seconds

Listed in: Science

What do I do if my patient has an infusion reaction on elotuzumab, even after premedication?

Published: Feb. 7, 2017, 8:04 p.m.
Duration: 1 minute 29 seconds

Listed in: Science